ZhongMei Capital jobs and careers

About ZhongMei Capital

ZhongMei Capital is a buy-out fund focused on sourcing and acquiring the US rights to early-stage biopharmaceutical assets originating in China. We then form a US NewCo to house the assets and generate clinical data in the United States in accordance with FDA guidelines. We provide value to our investors and partners by leveraging our network and expertise in China to bring otherwise inaccessible assets to the United States for development and commercialization.